DMSO Ligands Research Articles

The Chlorido-Bismuth Dication: A Potent Lewis Acid Captured in a Hepta-Coordinate Species with a Stereochemically Active Lone Pair.

The stabilization of simple, highly reactive cationic species in molecular complexes represents an important strategy to isolate and characterize compounds with uncommon or even unprecedented structural motifs and properties. Here we report the synthesis, isolation, and full characterization of chlorido-bismuth dications, stabilized only by monodentate dimethylsulfoxide (dmso) ligands: [BiCl(dmso)6][BF4]2 (1) and [BiCl(μ2-dmso)(dmso)4]2[BF4]4 (2). These compounds show unusual distorted pentagonal bipyramidal coordination geometries along with high Lewis acidities and have been analyzed by multinuclear NMR spectroscopy, elemental analysis, IR spectroscopy, single-crystal X-ray diffraction, and density functional theory calculations. Attempts to generate the bromido- and iodido-analogs gave dmso-stabilized tricationic bismuth species.

Cu‐Catalyzed Synthesis of 4H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐4‐ones: Molecular Docking Studies and Anti‐Proliferative Activities Against HepG2 Hepatocellular Carcinoma Cells

AbstractThe copper‐catalyzed regioselective domino synthesis of 4H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐4‐ones 3 through N,S‐arylation strategies has been accomplished. This transformation was operated by the reaction of 1‐bromo‐2‐iodobenzenes 1 with 2‐thioxo‐2,3‐dihydropyrimidin‐4(1H)‐ones 2 in the presence of trans‐4‐hydroxy‐L‐proline as a ligand in DMSO as a solvent. Using this method, a library of diversely functionalized 4H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐4‐one derivatives 3 were obtained in yields ranging 66–85 %. The described process revealed a very good tolerance to substituents on both 1‐bromo‐2‐iodobenzenes 1 and 2‐thioxo‐2,3‐dihydropyrimidin‐4(1H)‐ones 2. In addition, the reaction with 1,2‐diodobenzene yielded the corresponding 2‐methyl‐4H‐benzo[4,5]thiazolo[3,2‐a]pyrimidin‐4‐one (3 a) in 70 % yield. Docking studies explained that the derivatives 3 h, 3 e, and 3 p bind to the lipophilic pocket of the phosphoinositide 3‐kinase beta (PI3 Kβ) and epidermal growth factor receptor (EGFR) with high affinities. In addition, the complex 3 h‐4bfr formed a very stable complex with PI3 Kβ with the lowest binding free energy of −7.89 kcal/mol. The anti‐proliferative activity against HepG2 hepatocellular carcinoma cells was evaluated using MTT assay. The compound 3 h exhibited cytotoxic activity against HepG2 cells comparable to that of Erlotinib, a standard EGFR inhibitor (IC50 values of 19.1 and 14.7 μM). Four of the tested compounds (3 e, 3 f, 3 o, and 3 p) showed moderate anti‐proliferative activities (IC50 values of 53.9 to 92.2 μM).

Investigating the anti-filarial efficacy and molecular interactions of thiadiazol derivative: Insight from quantum chemical calculations, pharmacokinetics, and molecular docking studies

Parasitic infections such as lymphatic filariasis (elephantiasis) solely result from the infestation of a slender and thread-like worm. This condition precipitates swelling, often accompanied by skin alterations, potentially leading to substantial disability and disfigurement. Recent advancements in preventive measures for lymphatic filariasis encompass mass drug administration (MDA) involving antifilarial drugs. To that effect, this investigation employs an experimental and theoretical approach, utilizing the DFT/6–311++(2p,2d)/ωB97X-D level of theory, to evaluate the anti-filarial properties of a thiadiazol derivative, designated by the code (PTA). The comparative analysis of the spectroscopic data (FT-IR, UV, and NMR) was observed to be in good agreement. The geometry equilibration, it was observed that attributed to the influence of solvents and their properties, including the dielectric constant and polarity C18-S2 bond exhibited the highest bond length values 1.80208 (Å) in a gaseous environment. In the comparison of energy gaps, PTA_DMSO exhibited the smallest gap at 3.899 eV, while PTA_Water displayed a broader gap at 4.724 eV. PTA_Chloroform and PTA_Gas followed closely with energy gaps of 4.718 and 4.599 eV, respectively. The smaller energy gap observed in PTA_DMSO suggests higher reactivity and lower stability of the compound in this solvent. This finding underscores the potential efficacy of the ligand in DMSO as a promising drug candidate in this particular medium. From the molecular docking analysis shows the hydrogen bonds formed between 3VKL and PTA are four hydrogen bonds with a binding affinity of -4.6 kcal/mol, while with the two standard drugs, dimethylcarbamazine, one hydrogen bond with a binding affinity of -4.30 kcal/mol and albendazole with three hydrogen bonds with a binding affinity of -5.3 kcal/mol. Also, with 4BME protein, three hydrogen bonds with a binding affinity of -4.6 kcal/mol for PTA, one hydrogen bond for diethylcarbamazine with a binding affinity of -4.6 kcal/mol and two hydrogen bonds for albendazole with a binding affinity of -2.9 kcal/mol.

Unravelling the kinetics of electro- and photochemical S → O linkage isomerization in Ru(II)-NHC-DMSO complexes utilised for photoinduced substitution reactions.

Our recently reported Ru(III)-NHC complexes 1a and 1b were utilized as suitable precursors to prepare new Ru(II)-NHC-(DMSO)2 complexes 2a and 2b. Complexes 2a and 2b reacted with 2,2'-bipyridine to give complexes 3a and 3b, respectively, with substitution of only one of the DMSO ligands. All new complexes were characterized using various spectroscopic techniques and the molecular structures of 2a and 3a were determined using single-crystal X-ray diffraction technique. Complexes 2a, 2b, 3a, and 3b showed the S → O linkage isomerization of the DMSO ligand upon oxidation of the Ru centre from +II to +III, as confirmed by the thermodynamic and kinetic data obtained from cyclic voltammetry experiments. It was observed that in the bisdimethylsulfoxide complexes 2a and 2b, only one DMSO ligand isomerized, which was further corroborated by the computational studies performed to optimize the geometry of the possible linkage isomers of complexes 2a and 3a in +2 and +3 oxidation states, whereas complexes 3a and 3b showed a high preference for the O-bound isomer in the Ru(III) redox state. The role of NHC in stabilizing the mixed isomer in complexes 2a and 2b and preventing the isomerization of both DMSO ligands coordinated to the Ru centre was studied; moreover, NHC provided good solvent compatibility for photochemical S → O isomerization in all the complexes. Taking advantages of the photoinduced linkage isomerization in 2a and 2b, the synthesis of 3a and 3b was revisited and performed using 2a and 2b, respectively, following a photoinduced substitution reaction in the presence of 2,2'-bipyridine. The kinetics of the reversion from the O-bound to S-bound isomer was found to follow the DMSO-assisted intermolecular S → O isomerization pathway.

First Iridium(IV) Chloride-Dimethyl Sulfoxide Complex [H(dmso)2][IrCl5(dmso-κO)]: Synthesis and Structure along with Novel Polymorph Modifications of [H(dmso)2][trans-IrCl4(dmso-κS)2] and [H(dmso)][trans-IrCl4(dmso-κS)2

As evidenced by UV-Vis and EPR spectroscopies, the reaction of H2IrCl6·6H2O or Na2[IrCl6]·nH2O with DMSO results in a slow reduction of Ir(IV) avoiding the formation of Ir(IV) dimethyl sulfoxide complexes in measurable quantities. More specifically, we successfully isolated and solved the crystal structure of a sodium hexachloridoiridate(III), Na3[IrCl6]·2H2O, as a product of Na2[IrCl6]·nH2O reduction in an acetone solution. Furthermore, it was shown that [IrCl5(Me2CO)]- species is gradually formed in an acetone solution of H2IrCl6·6H2O upon storage. The reaction of DMSO with aged acetone solution of H2IrCl6·6H2O dominated by [IrCl5(Me2CO)]- affords a novel iridium(IV) chloride-dimethyl sulfoxide salt [H(dmso)2][IrCl5(dmso-κO)] (1). The compound was characterized by various spectroscopies (IR, EPR, UV-Vis) and X-ray diffraction techniques applied both to single-crystal and polycrystalline powder. The DMSO ligand is coordinated to the iridium site via the oxygen atom. New polymorph modifications of known iridium(III) complexes [H(dmso)2][trans-IrCl4(dmso-κS)2] and [H(dmso)][trans-IrCl4(dmso-κS)2] were isolated and structurally elucidated as byproducts of the above reaction.

Crystal-Liquid-Glass Transition and Near-Unity Photoluminescence Quantum Yield in Low Melting Point Hybrid Metal Halides.

Hybrid metal halides (HMHs) are a class of materials that combine extraordinary photophysical properties and excellent processability. Their chemical variability allows for the solid-liquid transition toward melt-processable HMHs. Herein, we report the design and synthesis of zero-dimensional HMHs [M(DMSO)6][SbCl6], where the isolated octahedra of [M(DMSO)6]3+ and [SbCl6]3- are alternatively aligned in the crystal structure. The luminescent center of [SbCl6]3- enables the photogeneration of self-trapped excitons, resulting in broadband photoluminescence with a large Stokes shift and a nearly 100% quantum yield. Meanwhile, the release of DMSO ligands from [M(DMSO)6]3+ is controlled by the M-O coordination and thus a low melting point of ∼90 °C is achieved for HMHs. Interestingly, the glass phase is obtained by melt quenching, with a sharp change in photoluminescence colors compared to the crystal phase of melt-processable HMHs. The robust crystal-liquid-glass transition opens a new avenue to tailoring structural disorder and optoelectronic performance in organic-inorganic materials.

Diminishing the catalyst concentration in the Cu(0)‐RDRP and ATRP synthesis of well‐defined low‐molecular weight poly(glycidyl methacrylate)

AbstractLow‐molecular weight (MW) solvent‐borne functional (meth)acrylic polymers find an important use in coating resins. However, when preparing such polymers through copper‐mediated reversible‐deactivation radical polymerization (RDRP), contamination with colored copper species and the use of expensive ligands represent significant obstacles from the industrial application viewpoint. Here, we investigated the possibilities of diminishing the catalyst levels in metallic coper‐mediated RDRP (Cu(0)‐RDRP) and atom transfer radical polymerization (ATRP) of a widely used functional monomer, glycidyl methacrylate (GMA), targeting a low MW of approximately 3000. Both Cu wire‐ and powder‐catalyzed Cu(0)‐RDRP provided well‐defined, low‐MW poly(GMA) at quantitative conversions when using an inexpensive PMDETA ligand in DMSO. However, only with Cu powder, the contamination of the final polymerization mixture with Cu species could be efficiently diminished to ≤66 ppm while maintaining the polymerization control. Additionally, the in situ block copolymerization was successfully demonstrated, furnishing a poly(GMA)‐b‐poly(MMA) mixture containing only 39 ppm of Cu in a process facilitated by the intrinsic reductive properties of the GMA's epoxide groups. Significantly, the targeted low‐MW poly(GMA) could also be synthesized by low‐catalyst‐concentration ATRP (CuBr/PMDETA system), obtaining well‐defined polymers with quantitative conversions at ca 50 ppm of Cu in the final mixture, both at r.t. and 50 °C.

1,2-Azolylamidino ruthenium(II) complexes with DMSO ligands: electro- and photocatalysts for CO2 reduction.

New 1,2-azolylamidino complexes fac-[RuCl(DMSO)3(NHC(R)az*-κ2N,N)]OTf [R = Me (2), Ph (3); az* = pz (pyrazolyl, a), indz (indazolyl, b)] are synthesized via chloride abstraction from their corresponding precursors cis,fac-[RuCl2(DMSO)3(az*H)] (1) after subsequent base-catalyzed coupling of the appropriate nitrile with the 1,2-azole previously coordinated. All the compounds are characterized by 1H NMR, 13C NMR and IR spectroscopy. Those derived from MeCN are also characterized by X-ray diffraction. Electrochemical studies showed several reduction waves in the range of -1.5 to -3 V. The electrochemical behavior in CO2 media is consistent with CO2 electrocatalytic reduction. The catalytic activity expressed as [icat(CO2)/ip(Ar)] ranged from 1.7 to 3.7 for the 1,2-azolylamidino complexes at voltages of ca. -2.7 to -3 V vs. ferrocene/ferrocenium. Controlled potential electrolysis showed rapid decomposition of the Ru catalysts. Photocatalytic CO2 reduction experiments using compounds 1b, 2b and 3b carried out in a CO2-saturated MeCN/TEOA (4 : 1 v/v) solution containing a mixture of the catalyst and [Ru(bipy)3]2+ as the photosensitizer under continuous irradiation (light intensity of 150 mW cm-2 at 25 °C, λ > 300 nm) show that compounds 1b, 2b and 3b allowed CO2 reduction catalysis, producing CO and trace amounts of formate. The combined turnover number for the production of formate and CO is ca. 100 after 8 h and follows the order 1b < 2b ≈ 3b.

Role of ancillary ligands in selectivity towards acceptorless dehydrogenation versus dehydrogenative coupling of alcohols and amines catalyzed by cationic ruthenium(II)-CNC pincer complexes.

An unexpected reversal in catalytic activity for acceptorless dehydrogenative coupling compared to acceptorless alcohol dehydrogenation has been observed using a series of cationic Ru(II)-CNC pincer complexes with different ancillary ligands. In continuation of our study of cationic Ru(II)-CNC pincer complexes 1a-6a, new complexes with bulky N-wingtips [Ru(CNCiPr)(CO)(PPh3)Br]PF6 (1b), [Ru(CNCCy)(CO)(PPh3)Cl]PF6 (1c), [Ru(CNCCy)(CO)(PPh3)H]PF6 (2c), [Ru(CNCiPr)(PPh3)2Cl]PF6 (3b), [Ru(CNCCy)(PPh3)2Cl]PF6 (3c), [Ru(CNCiPr)(PPh3)2H]PF6 (4b), [Ru(CNCCy)(PPh3)2H]PF6 (4c), [Ru(CNCiPr)(DMSO)2Cl]PF6 (6b), and [Ru(CNCCy)(DMSO)2Cl]PF6 (6c) [CNCR = 2,6-bis(1-alkylimidazol-2-ylidene)-pyridine] have been synthesized and the catalytic activities of the new complexes have been compared with their N-methyl analogues for transfer hydrogenation of cyclohexanone and acceptorless dehydrogenation of benzyl alcohol. Furthermore, all complexes have been utilized as catalysts in the dehydrogenative coupling reaction of benzyl alcohol with amines. While the catalytic activities of the new complexes for transfer hydrogenation and acceptorless alcohol dehydrogenation were found to be in line with the previously observed trend based on the ancillary ligands (CO > COD > DMSO > PPh3), for the acceptorless dehydrogenative coupling reaction, complexes containing PPh3 and DMSO ligands performed better compared to complexes containing CO and COD ligands. Based on NMR and mass investigation of catalytic reactions, a plausible mechanism has been suggested to explain the difference in catalytic activity and its reversal during the dehydrogenative coupling reaction. Furthermore, the substrate scope for the dehydrogenative coupling reaction of benzyl alcohol with a wide range of amines has been explored, including synthesizing some pharmaceutically important imines. All new complexes have been characterized by various spectroscopic techniques, and the structures of 4b and 6b have been confirmed by the single-crystal X-ray diffraction technique.

Photocrystallography of [Ru(bpy)2(dmso)2]2+ reveals an O-bonded metastable state.

We report the first instance of observing the phototriggered isomerization of dmso ligands on a bis sulfoxide complex, [Ru(bpy)2(dmso)2], in the crystalline solid state. The solid-state UV-vis spectrum of the crystal demonstrates an increase in optical density around 550 nm after irradiation, which is consistent with the solution isomerization results. Digital images of the crystal before and after irradiation display a notable color change (pale orange to red) and cleavage occurs along planes, (1̄01) and (100), during irradiation. Single crystal X-ray diffraction data also confirms that isomerization is occurring throughout the lattice and a structure that contains a mix of the S,S and O,O/S,O isomer was attained from a crystal irradiated ex situ. In situ irradiation XRD studies reveal that the percentage of the O-bonded isomer increases as a function of 405 nm exposure time.

Fluoro-Germanium (IV) Cations with Neutral Co-Ligands—Synthesis, Properties and Comparison with Neutral GeF4 Adducts

The reaction of [GeF4L2], L = dmso (Me2SO), dmf (Me2NCHO), py (pyridine), pyNO (pyridine-N-oxide), OPPh3, OPMe3, with Me3SiO3SCF3 (TMSOTf) and monodentate ligands, L, in a 1:1:1 molar ratio in anhydrous CH2Cl2 formed the monocations [GeF3L3][OTf]. These rare trifluoro-germanium (IV) cations were characterised by microanalysis, IR, 1H, 19F{1H} and, where appropriate, 31P{1H} NMR spectroscopy. The 19F{1H} NMR data show that in CH3NO2 solution the complexes exist as a mixture of mer and fac isomers, with the mer isomer invariably having the higher abundance. The X-ray structure of mer-[GeF3(OPPh3)3][OTf] is also reported. The attempts to remove a second fluoride using a further equivalent of TMSOTf and L were mostly unsuccessful, although a mixture of [GeF2(OAsPh3)4][OTf]2 and [GeF3(OAsPh3)3][OTf] was obtained using excess TMSOTf and OAsPh3. The reaction of [GeF4(MeCN)2] with TMSOTf in CH2Cl2 solution, followed by the addition of 2,2′:6′,2”-terpyridine (terpy) formed mer-[GeF3(terpy)][OTf], whilst a similar reaction with 1,4,7-trimethyl-1,4,7-triazacyclononane (Me3-tacn) in MeCN solution produced fac-[GeF3(Me3-tacn)][OTf]. Dicationic complexes bearing the GeF22+ fragment were isolated using the tetra-aza macrocycles, 1,4,7,10-tetramethyl-1,4,7,10-tetra-azacyclododecane (Me4-cyclen) and 1,4,8,11-tetramethyl-1,4,8,11-tetra-azacyclotetradecane (Me4-cyclam), which reacted with [GeF4(MeCN)2] and two equivalents of TMSOTf to cleanly form the dicationic difluoride salts, cis-[GeF2(Me4-cyclen)][OTf]2 and trans-[GeF2(Me4-cyclam)][OTf]2. The 19F{1H} NMR spectroscopy shows that in CH3NO2 solution there are four stereoisomers present for trans-[GeF2(Me4-cyclam)][OTf]2, whereas the smaller ring-size of Me4-cyclen accounts for the formation of only cis-[GeF2(Me4-cyclen)][OTf], and is confirmed crystallographically. New spectroscopic data are also reported for [GeF4(L)2] (L = dmso, dmf and pyNO). Density functional theory calculations were used to probe the effect on the bonding as fluoride ligands were sequentially removed from the germanium centre in the OPMe3 complexes.

Ancillary ligand effects and microwave‐assisted enhancement on the catalytic performance of cationic ruthenium(II)‐CNC pincer complexes for acceptorless alcohol dehydrogenation

The application of cationic Ru(II)‐CNC pincer complexes [Ru(CNC)(CO)(PPh3)Cl]PF6 (1), [Ru(CNC)(PPh3)2Cl]PF6 (2), [Ru(CNC)(η2:η2‐COD)Cl]PF6 (4), and [Ru(CNC)(DMSO)2Cl]PF6 (5) in acceptorless dehydrogenation of alcohols is reported under conventional “oil‐bath” and microwave heating conditions. The effect of different ancillary ligands (CO, PPh3, COD, and DMSO) have been demonstrated during catalysis. Complexes with more π‐acid ligands CO and COD perform better compared with those with PPh3 and DMSO ligands. A plausible mechanism is proposed based on NMR and mass investigation during the catalysis. The catalytic performance matches with the order of trans effect among the four ancillary ligands studied in these complexes. Further, a significant reduction in reaction time, as well as reaction temperature, was observed for catalytic reactions under the microwave‐assisted reaction compared with the oil‐bath heating reaction.

The role of hydrolysis in biological effects of molybdenum cluster with DMSO ligands.

Biological applications of octahedral molybdenum cluster complexes are complicated by their hydrolytic instability, since hydrolysis leads to irreversible changes in the structure and properties of these compounds. On the other hand, if such changes are thoroughly investigated and understood, the hydrolysis process can become an important tool for regulating specific biological effects of the clusters. In this work, we demonstrate how the luminescence and biological properties (cellular uptake, cytotoxicity in the dark and photodynamic effect) of highly unstable cluster complex [{Mo6I8}(DMSO)6](NO3)4 change along with the degree of hydrolysis. Particularly, cluster solution preliminarily aged in water demonstrated lower dark and higher photoinduced cytotoxicity and higher cellular uptake in comparison with fresh solution.

Cover Feature: Synthesis and Characterization of a Cobalt(III) Corrole with an S‐Bound DMSO Ligand (Eur. J. Inorg. Chem. 35/2021)

Cover Feature: Synthesis and Characterization of a Cobalt(III) Corrole with an S‐Bound DMSO Ligand (Eur. J. Inorg. Chem. 35/2021)

Crystal structure, MEP/DFT/XRD, thione ⇔ thiol tautomerization, thermal, docking, and optical/TD-DFT studies of (E)-methyl 2-(1-phenylethylidene)-hydrazinecarbodithioate ligand

As small-molecule (E)-methyl 2-(1-phenylethylidene)hydrazinecarbodithioate has been prepared and characterized by X-ray single-crystal analysis. In order to elucidate the nature of the intermolecular interactions in the structural lattice, the Hirshfeld surface analysis (HSA) calculation was correlated to the XRD-packing result. Moreover, the XRD bond lengths and angles were compared to their DFT/B3LYP/6-311G(d,p) relative parameters. Considering the thione isomer as a kineticly favoured isomer, the single proton intra-migration from H-N to form S-H thionethiol tautomerization process was successfully computed via QST2 model. Additionally, Mulliken Atomic Charge (MAC), Natural Population Analysis (NPA), and Molecular Electrostatic Potential (MEP) analyses were carried out to confirm this process. The electron transfer and optical behavior of the ligand in DMSO have been exanimated with TD-DFT and HOMO/LUMO calculations. The thermal behavior of the compound was determined in an open room condition via TG/DTG. The two identified isomers of (E)-methyl 2-(1-phenylethylidene)-hydrazinecarbodithioate (thione and thiol forms) were docked against TcAChE (PDB:1EVE) revealed, conspicuous, different protein–drug structures, however, reflects identical docking scores (−7.2 Kcal/mol each), which is compared to the standard donepezil drug used in this study.

Synthesis, characterization and anticancer properties of platinum(II) complexes bearing chiral azomethine ligands

AbstractPt(II) complexes bearing one N‐salicylidene‐(S)‐1‐phenylethylamine [HL(S)] or N‐salicylidene‐(R)‐1‐phenylethylamine [HL(R)] were synthesized and characterized by electrospray ionization mass spectroscopy (ESI‐MS), Fourier‐transform infrared (FT‐IR), nuclear magnetic resonance (NMR) and circular dichroism (CD) spectroscopies. The results of the micro‐analytic and spectroscopic methods disclosed that the reaction of K2PtCl4 with the chiral azomethine ligand in DMSO produced both trans‐ and cis‐[Pt(II)L(DMSO)Cl]. Then only trans‐[Pt(II)L(DMSO)Cl] isomers in Na2CO3 solution can transform to Pt(II) complexes 3 in coordination of the ligands to platinum as tridentate C,N,O‐donors. The photophysical properties of obtained platinum(II) complexes were studied by UV‐visible and luminescent spectra. The results showed that they all exhibited emission in the visible region. Anticancer properties in vitro of obtained Pt(II) complexes were scaned for KB and HepG‐2 cancer cell lines. They had good activity for the tested cancer cells. The cis‐Pt(II) complexes possessed higher anticancer activity than trans‐Pt(II) complexes and R‐enantiomers were found to be more cytotoxic than S‐enantiomers.

Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions

IntroductionThe radiohybrid (rh) prostate-specific membrane antigen (PSMA)-targeted ligand [18F]Ga-rhPSMA-7 has previously been clinically assessed and demonstrated promising results for PET-imaging of prostate cancer. The ligand is present as a mixture of four stereoisomers ([18F]Ga-rhPSMA-7.1, − 7.2, − 7.3 and − 7.4) and after a preclinical isomer selection process, [18F]Ga-rhPSMA-7.3 has entered formal clinical trials. Here we report on the establishment of a fully automated production process for large-scale production of [18F]Ga-rhPSMA-7/ -7.3 under GMP conditions (EudraLex).Methods[18F]Fluoride in highly enriched [18O]H2O was retained on a strong anion exchange cartridge, rinsed with anhydrous acetonitrile and subsequently eluted with a solution of [K+ ⊂ 2.2.2]OH− in anhydrous acetonitrile into a reactor containing Ga-rhPSMA ligand and oxalic acid in DMSO. 18F-for-19F isotopic exchange at the Silicon-Fluoride Acceptor (SiFA) was performed at room temperature, followed by dilution with buffer and cartridge-based purification. Optimum process parameters were determined on the laboratory scale and thereafter implemented into an automated synthesis. Data for radiochemical yield (RCY), purity and quality control were analyzed for 243 clinical productions (160 for [18F]Ga-rhPSMA-7; 83 for [18F]Ga-rhPSMA-7.3).ResultsThe automated production of [18F]Ga-rhPSMA-7 and the single isomer [18F]Ga-rhPSMA-7.3 is completed in approx. 16 min with an average RCY of 49.2 ± 8.6% and an excellent reliability of 98.8%. Based on the different starting activities (range: 31–130 GBq, 89 ± 14 GBq) an average molar activity of 291 ± 62 GBq/μmol (range: 50–450 GBq/μmol) was reached for labeling of 150 nmol (231 μg) precursor. Radiochemical purity, as measured by radio-high performance liquid chromatography and radio-thin layer chromatography, was 99.9 ± 0.2% and 97.8 ± 1.0%, respectively.ConclusionThis investigation demonstrates that 18F-for-19F isotopic exchange is well suited for the fast, efficient and reliable automated routine production of 18F-labeled PSMA-targeted ligands. Due to its simplicity, speed and robustness the development of further SiFA-based radiopharmaceuticals is highly promising and can be of far-reaching importance for future theranostic concepts.

Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes.

Type IV secretion systems are protein secretion machineries that are frequently used by pathogenic bacteria to inject their virulence factors into target cells of their respective hosts. In the case of the human gastric pathogen Helicobacter pylori, the cytotoxin-associated gene (Cag) type IV secretion system is considered a major cause for severe disease, such as gastric cancer, and thus constitutes an attractive target for specific treatment options against H. pylori infections. Here, we have used a Cag type IV secretion reporter assay for screening a repurposing compound library for inhibitors targeting this system. We found that the antitumor agent cisplatin, a platinum coordination complex that kills target cells by formation of DNA crosslinks, is a potent inhibitor of the Cag type IV secretion system. Strikingly, we found that this inhibitory activity of cisplatin depends on a ligand exchange reaction which incorporates a solvent molecule (dimethylsulfoxide) into the complex, a modification which is known to be deleterious for DNA crosslinking, and for its anticancer activity. We extended our analysis to several analogous platinum complexes containing N-heterocyclic carbene, as well as DMSO or other ligands, and found varying inhibitory activities toward the Cag system which were not congruent with their DNA-binding properties, suggesting that protein interactions may cause the inhibitory effect. Inhibition experiments under varying conditions revealed effects on adherence and bacterial viability as well, and showed that the type IV secretion-inhibitory capacity of platinum complexes can be inactivated by sulfur-containing reagents and in complex bacterial growth media. Taken together, our results demonstrate DNA binding-independent inhibitory effects of cisplatin and other platinum complexes against different H. pylori processes including type IV secretion.

Direct Formation of 2-Substituted 2H-Indazoles by a Pd-Catalyzed Reaction between 2-Halobenzyl Halides and Arylhydrazines.

A direct and operationally simple method for the regioselective synthesis of 2-aryl-substituted 2H-indazoles is reported. The Pd-catalyzed reaction between easily available 2-bromobenzyl bromides and arylhydrazines employing Cs2CO3 as the base and t-Bu3PHBF4 as the ligand in DMSO at 120 °C in a sealed tube delivers the 2-substituted-2H-indazoles in a single synthetic step with yields up to 79%. The new method is based on a regioselective intermolecular N-benzylation followed by intramolecular N-arylation and oxidation.

A Bis-Chelating / Ligand for the Synthesis of Heterobimetallic Platinum(II)/Rhenium(I) Complexes: Tools for the Optimization of a New Class of Platinum(II) Anticancer Agents.

The two independent and coordination sites of a newly synthesized bis[2-(hydroxyphenyl)-1,2,4-triazole] platform have been exploited to prepare four monometallic neutral ()PtII complexes carrying DMSO, pyridine, triphenylphosphine, or N-heterocyclic carbene as the fourth ligand. Then, the second coordination site was used to introduce an IR-active rhenium tricarbonyl entity, affording the four corresponding heterobimetallic neutral PtII /ReI complexes, as well as a cationic PtII /ReI derivative. X-ray crystallographic studies showed that distortion of the organic platform occurred to accommodate the coordination geometry of both metal centers. No ligand exchange or transchelation occurred upon incubation of the PtII complexes in aqueous environment or in the presence of FeIII , respectively. The antiproliferative activity of the ligand and complexes was first screened on the triple-negative breast cancer cell line MDA-MB-231. Then, the IC50 values of the most active candidates were determined on a wider panel of human cancer cells (MDA-MB-231, MCF-7, and A2780), as well as on a nontumorigenic cell line (MCF-10A). Low micromolar activities were reached for the complexes carrying a DMSO ligand, making them the first examples of highly active, but hydrolytically stable, PtII complexes. Finally, the characteristic mid-IR signature of the {Re(CO)3 } fragment in the Pt/Re heterobimetallic complexes was used to quantify their uptake in breast cancer cells.